相关实验视频
Updated: May 6, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.5K
合成宿主防御抑制了SARS-CoV-2的复制体外
Rhodri Harfoot1, Blair Lawley1, Leonor C Hernández2
1Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Antimicrobial agents and chemotherapy
|June 23, 2025
概括
D-3006是一种合成,在体外有效抑制SARS-CoV-2变种和流感A病毒. 这种宿主防御显示出广泛的抗病毒潜力和与remdesivir的协同效应,用于COVID-19治疗.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 尽管进行了广泛的测试,但抗病毒药物对SARS-CoV-2的成功有限.
- 由于蛋白酶耐药性,D-enantiomeric的抗病毒特性尚未得到充分探索.
- 需要针对新出现的呼吸道病毒制定新的治疗策略.
研究的目的:
- 为了描述D-3006的体外抗病毒活性,一种合成的D-enantiomeric宿主防御.
- 评估D-3006对各种SARS-CoV-2变种和其他包裹病毒的疗效.
- 研究D-3006.的作用机制和潜在的协同效应.
主要方法:
- 在体外测试D-3006对真实的SARS-CoV-2变体 (祖先,Mu,Delta,Omicron BA.1) 的测试.
- 对D-3006对beta-冠状病毒尖端伪型lentiviruses的影响的评估.
- 评估D-3006与雷梅西维尔联合使用以及对A型流感病毒 (H1N1) 的检测.
- 负染色传导电子显微镜用于作用机制研究.
主要成果:
- D-3006证明安全有效地抑制了SARS-CoV-2变种的尖端介导入口 (EC50: 1.575.37 μg/mL; CC50: 430 μg/mL).
- 当D-3006与remdesivir结合使用时,观察到协同抗病毒活性.
- 在实验室中,D-3006还抑制了A型流感病毒 (H1N1) 复制.
- 机制可能涉及对病毒膜的非特异性结合,导致聚合和抑制进入.
结论:
- D-3006在体外表现出强大的抗病毒活性,对抗SARS-CoV-2和A型流感病毒.
- 它的蛋白酶耐药性和广谱潜力使其成为呼吸道病毒感染的有希望的候选人.
- 使用D-3006和现有的抗病毒药物 (如雷梅西维尔) 的联合治疗需要进一步调查.
相关概念视频
02:50Conjugated Proteins
21.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.1K
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58